Skip to main content
. 2023 Jun 15;114(6):956–966. doi: 10.17269/s41997-023-00784-3

Table 2.

Prevalence of dispensed benzodiazepine and opioid prescriptions among people with healthcare encounters for benzodiazepine-related toxicity, 2013 to 2020

Measure 2013 2014 2015 2016 2017 2018 2019 2020 p-value
Number of benzodiazepine-related toxicity encounters 3820 3856 3967 4149 4693 4487 3874 3828
Benzodiazepine prescribing history
  Active prescription 2332 (61.1%) 2419 (62.7%) 2384 (60.1%) 2400 (57.9%) 2445 (52.1%) 2434 (54.3%) 2086 (53.9%) 1872 (48.9%)  < 0.0001
  Prescription in the previous 30 days 2417 (63.3%) 2475 (64.2%) 2492 (62.8%) 2525 (60.9%) 2621 (55.9%) 2566 (57.2%) 2259 (58.3%) 2045 (53.4%)  < 0.0001
  Prescription in the previous 180 days 2945 (77.1%) 3033 (78.7%) 3085 (77.8%) 3123 (75.3%) 3302 (70.4%) 3241 (72.2%) 2843 (73.4%) 2571 (67.2%)  < 0.0001
Active opioid prescription 738 (19.3%) 714 (18.5%) 741 (18.7%) 662 (16.0%) 716 (15.3%) 671 (15.0%) 580 (15.0%) 539 (14.1%)  < 0.0001
Active opioid and benzodiazepine prescriptions 600 (15.7%) 569 (14.8%) 577 (14.5%) 500 (12.1%) 532 (11.3%) 507 (11.3%) 435 (11.2%) 391 (10.2%)  < 0.0001